Australia is a world leader in its efforts to eliminate hepatitis C and to improve the health of people who use drugs. But COVID-19, on a backdrop of economic uncertainty, anxiety and unemployment has the potential to disrupt our support, prevention and cure efforts – especially given the populations most impacted by hepatitis C and drug dependence are some of our most vulnerable Australians.
On behalf of Utilitarian Conferences Gathering, we extend a warm greeting in welcoming you to the Gastroenterology Conference happening during July 27-28, 2020, in Berlin, Germany. The theme of the Conference is Gastroenterology – Reinventing the life balance. It is an auspicious time to make contact, discuss and shar
The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.
The INHSU annual conference is a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C.
The 1st Regional Conference on Hepatitis Care in Substance Users (INHSU Africa) will take place on the 19 – 20 February 2020, Cape Town, South Africa.
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).
The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016.
The 3rd European Chemsex Forum will be a 2½ day, multi-disciplinary event, in Paris, 14-16 November 2019.
Activities include an evening opening with keynote speeches on Thursday, the Data and Evidence Day on Friday, and the Community Mobilisation Day on Saturday.
The 8th INHSU conference covers the latest advances on hepatitis C epidemiology, management and treatment of viral hepatitis among people who use drugs, with a specific focus on hepatitis C.
Through the dissemination of scientific knowledge, the conference aims to contribute to the World Health Organization’s goal of eliminating hepatitis C by 2030.
The HepHIV2019 conference, which is organised jointly with the 3-year EU funded joint action INTEGRATE, will take place 28-30 January 2019 in Bucharest, Romania.
The theme of the conference is the Challenges of Timely and Integrated Testing and Care.
The main objectives of the HepHIV 2019 conference are to:
State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
What is already known about this topic?
The United States has experienced a sharp increase in hepatitis C virus (HCV) incidence that can be attributed to injection drug use. Some states have used public health laws and treatment policies to reduce the risk for transmission of HCV infections among persons who inject drugs.
What is added by this report?